Skip to main content
. 2016 Jun 20;18(7):615–622. doi: 10.1016/j.hpb.2016.05.010

Table 2.

Histopathological findings and disease recurrence

Number or Value
Diagnoses
Pancreatic ductal adenocarcinoma 26
Common bile duct adenocarcinoma 10
Intraductal papillary mucinous neoplasia 1
Serous cystic neoplasia 1
Pancreatic neuroendocrine tumor 5
Chronic pancreatitis 2
Tumor stage (n = 41)a
1 0
2 2
3 39
4 0
Lymph node status (positive/negative) n = 41 30/11
Lymph node ratio (<0,2/≥0,2) n = 41 23/18
Tumor size, mm; mean (±SD) 45 ± 37
R-status (R0/R1), n = 41 15/26
Recurrence (yes/no), n = 41 30/11
Site of recurrence
Local only 13
Distant only 8
Local and distant 9
Survival, PDAC, months; median (IQR) 17 (13–31)
Survival, CBDCa, months; median (IQR) 17 (5–27)
Disease-free survival, PDAC, months; median (IQR) 12 (8–17.5)
Disease-free survival, CBDCa, months; median (IQR) 9 (4–21)
Follow-up, entire study population, months; median (IQR) 13 (7–30)
Time to last CT, months; median (IQR) 8 (4.5–16.5)
a

UICC, TNM classification of malignant tumors. 7th. Ed. Oxford:Wiley-Blackwell, 2009.